INVESTORS

Investor Relations

Recent News

Investor Alerts

May 10, 2017

Sierra Oncology Receives Clearance to Enhance Ongoing Clinical Trials for SRA737

May 9, 2017

Sierra Oncology Reports First Quarter 2017 Results

Apr 3, 2017

Sierra Oncology Collaborator ICR Reports Preclinical Synthetic Lethality Data for Chk1 Inhibitor SRA737 at AACR

View all news releases

Events and Webcasts

BIOTech Showcase 2017 San Francisco

Wednesday, January 11, 2017

8:00am PST

View all events and webcasts

Annual Meeting of Stockholders

Tuesday, June 13, 2017
10:00 am PT
Fairmont Hotel Vancouver, 900 West Georgia Street, Vancouver, BC

Proxy Documents:

Latest Presentation

Beyond PARP - Next Generation DDR Therapeutics, Q2 2017

View All Presentations

Publications

Screening the druggable genome for synthetic lethal interactions with the CHK1 inhibitor PNT737 (SRA737)

VIEW PUBLICATIONS